Blood pressure relationship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels

Biological Trace Element Research

Volumn 104, Issue 2, 2005, Pages 141-149

  Dursun, Nurcan ^a   Arifoglu, Canan ^a   Süer, Cem ^a   Keskinol, Leyla ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Blood pressure; Creatinine clearance; L NAME; Lead; Nitric oxide; Renal blood flow

Indexed keywords

LEAD; NITRIC OXIDE; CREATININE; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LEAD BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SODIUM URINE LEVEL; VASCULAR RESISTANCE; ANIMAL; BIOSYNTHESIS; BLOOD; BLOOD FLOW; DRUG ANTAGONISM; DRUG EFFECT; KIDNEY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; URINE; VASCULARIZATION;

ANIMALIA;

ANIMALS; BLOOD PRESSURE; CREATININE; KIDNEY; LEAD; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW;

EID: 23844531270     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:104:2:141     Document Type: Article

References (25)

1. W. R. Harlan, The relationship of blood lead levels to blood pressure in the us population, Environ. Health Perspect. 78, 9-13 (1988).
2. H. C. Gonick, Y. Ding, S. C. Bandy, Z. Ni, and N. D. Vaziri, Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species, Hypertension 30, 1487-1492 (1997).
3. N. D. Vaziri, Y. Ding, Z. Ni, and H. C. Gonick, Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy, Kidney Int. 52, 1042-1046 (1997).
4. N. D. Vaziri, Y. Ding, Z. Ni, and H. C. Gonick, Nitric oxide synthase expression in course endothelial cells; role of superoxide, Hypertension 34, 558-562 (1999).
5. N. D. Vaziri, K. Liang, and Y. Ding, Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension, Kidney Int. 56, 1492-1498 (1999b).
6. D. A. Tsao, H. S. Yu, J. T. Cheng, C. K. Ho, and H. R. Chang, The change of beta-adrenergic system in lead-induced hypertension, Toxicol. Appl. Pharmacol. 164, 127-133 (2000).
7. M. Carmignani, P. Buscolo, A. Poma, and A. R. Volpe, Kininergic system and arterial hypertension following chronic exposure to inorganic lead, Immunopharmacology 44, 105-110 (1999).
8. F. Khalil-Manesh, H. D. Gonick, E. W. S. Weiler, B. Prins, M. A. Weber, and R. E. Purdy, Lead induced hypertension possible role of endothelial factors, Am. J. Hypertens. 6, 723-729 (1993).
9. S. W. Watts, S. Chai, and R. C. Webb, Lead acetate-induced contratcion in rabit mesenteric artery: interaction with calcium and protein kinase C, Toxicology 99, 55-56 (1995).
10. H. C. Gonick, Y. Ding, and N D. Vaziri, Effect of low lead exposure on eicosanoid excretion in rats, Prostaglandins Other Lipid Mediat. 55, 77-82 (1998).
11. M. Carmignani, P. Boscolo, A. Poma, and A. R. Volpe, Catchomamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment, Life Sci. 68, 401-415 (2000).
12. Y. Ding, N. D. Vaziri, and H. C. Gonick, Lead-induced hypertension. II. Response to seguential of L-arginine, superoxide dismutase and nitroprusside, Environ. Res. 76, 107-113 (1998).
13. L. T. Dijkhorst-Oei and H. A. Koomans, Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans, Nephrol. Dial. Transplant. 13, 587-593 (1998).
14. S. Harada, S. Tokunaga, M. Momohara, et al., Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits, Circ. Res. 72, 511-516 (1993).
15. B. Halliwell, What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett. 411, 157-160 (1997).
16. H. H. Draper and M. Hadley Malondialdehyde determination as on index of lipid peroxidation. Methods Enzymol. 186, 421-431 (1990).
17. K. Arto and T. Sandra, The calcium dependent nitric oxide production of human vascular endothelial cell in preeclamsia, Am. J. Obstet. Gynecol. 174, 1056-1060 (1996).
18. V. D. Vaziri, Y. Ding, and Z. Ni, Compensatory upregulation of nitric oxide synthase isoforms in lead induced hypertension; reversal by a superoxide dismutase-mimetic drug, J. Pharmacol. Exp. Ther. 298, 679-685 (2001).
19. R. Kim, D. Sparrow, S. Weiss, C. Wager, and H. Hu, A longitudinal study of low-level exposure and impairment of renal function. The Normative Aging Study, JAMA 275, 1177-1781 (1996).
20. J. Staessen, Low-level lead exposure, renal function and blood pressure, Verh. K. Acad. Genesskd. Belg. 57(6), 527-574 (1995).
21. Y. Ding, H. C. Gonick, N. D. Vaziri, K. Liang, and L. Wei, Lead induced hypertension. III Increased hidroxyl radical production, Am. J. Hypertens. 14, 169-173 (2001).
22. Y. Ding, C. Harvey, H. C. Gonick, and N. D. Vazin, Lead promotes hydroxyl radical generation and lipid peroxidation in caltured aortic endothelial cell, Am. J. Hypertens. 13, 552-555 (2000).
23. N. Dursun and A. Tutu, Chronic occupational lead exposure and thyroid function. J. Trace Elements Exp. Med. 12(1), 45-49 (1999).
24. N. Dursun and R. Saraymen, Chronic occupational lead exposure and testicular function, Trace. Elements Electrolytes 54(2), 64-68 (2001).
25. N. Dursun, P. Dogan, and H. Donmez, Plasma and erythrocyte lipid peroxide levels in workers with occupational exposure to lead, Biol. Trace Element Res. 82(1-3), 29-34 (2001).